Found: 88
Select item for more details and to access through your institution.
CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls.
- Published in:
- 2020
- By:
- Publication type:
- journal article
α-Synuclein species as potential cerebrospinal fluid biomarkers for dementia with lewy bodies.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A user's guide for α-synuclein biomarker studies in biological fluids: Perianalytical considerations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Inhibition of alpha-synuclein seeded fibril formation and toxicity by herbal medicinal extracts.
- Published in:
- BMC Complementary Medicine & Therapies, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12906-020-2849-1
- By:
- Publication type:
- Article
Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41531-021-00203-9
- By:
- Publication type:
- Article
Early-onset parkinsonism in a pedigree with phosphoglycerate kinase deficiency and a heterozygous carrier: do PGK-1 mutations contribute to vulnerability to parkinsonism?
- Published in:
- NPJ Parkinson's Disease, 2017, v. 3, n. 1, p. N.PAG, doi. 10.1038/s41531-017-0014-4
- By:
- Publication type:
- Article
Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies.
- Published in:
- Acta Neuropathologica Communications, 2020, v. 8, n. 1, p. 1, doi. 10.1186/s40478-020-00985-8
- By:
- Publication type:
- Article
Paving the Way toward Personalized Medicine: Current Advances and Challenges in Multi-OMICS Approach in Autism Spectrum Disorder for Biomarkers Discovery and Patient Stratification.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 1, p. 41, doi. 10.3390/jpm11010041
- By:
- Publication type:
- Article
Elevated expression of CYP1A1 and γ-SYNUCLEIN in human ectopic (ovarian) endometriosis compared with eutopic endometrium.
- Published in:
- Molecular Human Reproduction, 2008, v. 14, n. 11, p. 655, doi. 10.1093/molehr/gan056
- By:
- Publication type:
- Article
Disrupting the α-synuclein-ESCRT interaction with a peptide inhibitor mitigates neurodegeneration in preclinical models of Parkinson's disease.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37464-2
- By:
- Publication type:
- Article
Prion-like α-synuclein pathology in the brain of infants with Krabbe disease.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Bidirectional gut-to-brain and brain-to-gut propagation of synucleinopathy in non-human primates.
- Published in:
- 2020
- By:
- Publication type:
- journal article
α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
- Published in:
- Brain: A Journal of Neurology, 2020, v. 143, n. 1, p. 249, doi. 10.1093/brain/awz380
- By:
- Publication type:
- Article
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration.
- Published in:
- 2019
- By:
- Publication type:
- journal article
α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Brain propagation of transduced α-synuclein involves non-fibrillar protein species and is enhanced in α-synuclein null mice.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Correlated levels of cerebrospinal fluid pathogenic proteins in drug‐naïve Parkinson's disease: Biomarkers (non‐neuroimaging) / Differential diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.036258
- By:
- Publication type:
- Article
O2‐09‐04: HARMONIZATION OF IMMUNOCHEMICAL METHODS FOR MEASUREMENT OF α‐SYNUCLEIN IN HUMAN CEREBROSPINAL FLUID: A ROUND ROBIN STUDY APPROACH.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P642, doi. 10.1016/j.jalz.2018.06.2691
- By:
- Publication type:
- Article
Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 8, p. 7443, doi. 10.3390/ijms24087443
- By:
- Publication type:
- Article
Circulating MicroRNA Profiling Identifies Distinct MicroRNA Signatures in Acute Ischemic Stroke and Transient Ischemic Attack Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 1, p. 108, doi. 10.3390/ijms24010108
- By:
- Publication type:
- Article
Structural and Biophysical Characterization of Stable Alpha-Synuclein Oligomers.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 14630, doi. 10.3390/ijms232314630
- By:
- Publication type:
- Article
Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 11, p. 6144, doi. 10.3390/ijms23116144
- By:
- Publication type:
- Article
Identification of Novel Circulating miRNAs in Patients with Acute Ischemic Stroke.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 3387, doi. 10.3390/ijms23063387
- By:
- Publication type:
- Article
CSF Biomarkers Reflecting Protein Pathology and Axonal Degeneration Are Associated with Memory, Attentional, and Executive Functioning in Early-Stage Parkinson′s Disease.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8519, doi. 10.3390/ijms21228519
- By:
- Publication type:
- Article
Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 19, p. 7353, doi. 10.3390/ijms21197353
- By:
- Publication type:
- Article
Elevated levels of cerebrospinal fluid α-synuclein oligomers in healthy asymptomatic LRRK2 mutation carriers.
- Published in:
- Frontiers in Aging Neuroscience, 2014, v. 6, p. 1, doi. 10.3389/fnagi.2014.00248
- By:
- Publication type:
- Article
Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity.
- Published in:
- Frontiers in Aging Neuroscience, 2014, v. 6, p. 1, doi. 10.3389/fnagi.2014.00197
- By:
- Publication type:
- Article
ALPHA-SYNUCLEIN SPECIES AS POTENTIAL CSF BIOMARKERS FOR DEMENTIA WITH LEWY BODIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P338, doi. 10.1016/j.jalz.2017.06.063
- By:
- Publication type:
- Article
PERFORMANCE EVALUATION OF NEW ABSORBANCE-BASED ELISAS FOR MEASURING DIFFERENT ALPHA-SYNUCLEIN (A-SYN) SPECIES IN CSF AND PLASMA.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P677, doi. 10.1016/j.jalz.2016.06.1330
- By:
- Publication type:
- Article
STANDARDIZATION OF PRE-ANALYTICAL PROCEDURES FOR COLLECTION AND STORAGE OF CSF FOR THE MEASUREMENT OF NEUROGRANIN TRUNC P75 AND A-SYNUCLEIN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1155, doi. 10.1016/j.jalz.2016.07.059
- By:
- Publication type:
- Article
Quantification of CSF and blood alpha-synuclein as a diagnostic marker for synucleinopathies
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease.
- Published in:
- Scientific Reports, 2017, p. 40263, doi. 10.1038/srep40263
- By:
- Publication type:
- Article
Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123162
- By:
- Publication type:
- Article
α-Synuclein Levels in Blood Plasma from LRRK2 Mutation Carriers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052312
- By:
- Publication type:
- Article
Cerebrospinal Fluid α -Synuclein Species in Cognitive and Movements Disorders.
- Published in:
- Brain Sciences (2076-3425), 2021, v. 11, n. 1, p. 119, doi. 10.3390/brainsci11010119
- By:
- Publication type:
- Article
RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies.
- Published in:
- Biomolecules (2218-273X), 2021, v. 11, n. 6, p. 820, doi. 10.3390/biom11060820
- By:
- Publication type:
- Article
Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0241773
- By:
- Publication type:
- Article
Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation.
- Published in:
- Journal of Neuroscience, 2005, v. 25, n. 10, p. 2455, doi. 10.1523/JNEUROSCI.4391-04.2005
- By:
- Publication type:
- Article
Novel engineered nanobodies specific for N‐terminal region of alpha‐synuclein recognize Lewy‐body pathology and inhibit in‐vitro seeded aggregation and toxicity.
- Published in:
- FEBS Journal, 2022, v. 289, n. 15, p. 4657, doi. 10.1111/febs.16376
- By:
- Publication type:
- Article
Baicalein Inhibits Formation of α-Synuclein Oligomers within Living Cells and Prevents Aβ Peptide Fibrillation and Oligomerisation.
- Published in:
- ChemBioChem, 2011, v. 12, n. 4, p. 615, doi. 10.1002/cbic.201000604
- By:
- Publication type:
- Article
Fibrillar form of α-synuclein-specific scFv antibody inhibits α-synuclein seeds induced aggregation and toxicity.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-65035-8
- By:
- Publication type:
- Article
Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Detection of elevated levels of soluble {alpha}-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies.
- Published in:
- Brain: A Journal of Neurology, 2009, v. 132, n. 4, p. 1093
- By:
- Publication type:
- Article
Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2014, v. 6, n. 3, p. 1, doi. 10.1186/alzrt255
- By:
- Publication type:
- Article
Investigating the presence of doubly phosphorylated α‐synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.
- Published in:
- Brain Pathology, 2020, v. 30, n. 4, p. 831, doi. 10.1111/bpa.12845
- By:
- Publication type:
- Article
γ-Synuclein and the progression of cancer.
- Published in:
- FASEB Journal, 2007, v. 21, n. 13, p. 3419, doi. 10.1096/fj.07-8379rev
- By:
- Publication type:
- Article
Detection of oligomeric forms of α-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
- Published in:
- FASEB Journal, 2006, v. 20, n. 3, p. 419, doi. 10.1096/fj.03-1449com
- By:
- Publication type:
- Article
A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
- Published in:
- FASEB Journal, 2004, v. 18, n. 11, p. 1315, doi. 10.1096/fj.03-1346fje
- By:
- Publication type:
- Article
α-Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.
- Published in:
- FASEB Journal, 2003, v. 17, n. 13, p. 1945, doi. 10.1096/fj.03-0098fje
- By:
- Publication type:
- Article
Parkinson's disease biomarkers based on α‐synuclein.
- Published in:
- Journal of Neurochemistry, 2019, v. 150, n. 5, p. 626, doi. 10.1111/jnc.14809
- By:
- Publication type:
- Article